At this time, all participants are in a listen-only mode. The QuidelOrtho board is composed of 8 former Quidel board members and 4 former Ortho board members. Welcome to the QuidelOrtho second quarter 2022 financial results conference call and webcast. We are shaping the future of diabetes care with innovative technology to empower clinicians to make better treatment decisions and improve the quality of life for diabetes patients of all ages. Former Quidel stockholders received one share of QuidelOrtho common stock for each share of Quidel common stock. Under the terms of the agreement governing the transaction, former Ortho shareholders received $7.14 in cash and 0.1055 shares of QuidelOrtho common stock for each Ortho common share. We look forward to executing on our growth strategy as QuidelOrtho and enhancing care across the testing continuum while driving long-term value creation for our stockholders.” Regionals four clinic locations and Cherokee County Public Health have limited inventory of the FREE Quidel QuickVue At-Home Rapid Test Kits available. “There is a lot of important work ahead of us to deliver on our targeted synergies and new product introductions and we are energized and poised to excel in our combined mission to deliver advanced diagnostics to improve human health. Business Wire QuidelOrtho Reports First Quarter 2023 Financial Results ♱6 min read Highlights First quarter revenue of 846.1 million decreased by 16 as reported with non-respiratory revenue up. “We are very excited to bring together the talented and experienced teams of both Quidel and Ortho who share a commitment to the employees, customers, patients, and the communities we serve,” said Douglas Bryant, chairman and chief executive officer of QuidelOrtho. QuidelOrtho will trade on the Nasdaq Global Select Market under the symbol “QDEL.” The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 employees. With complementary areas of focus, the combined company will also operate with global reach and scale, maintaining the speed and agility that is fundamental to enhance Quidel’s current strategic approach.The previously announced transaction combining Quidel Corporation and Ortho Clinical Diagnostics Holdings plc, creating QuidelOrtho, a leading in vitro diagnostics company, has been completed. (RTTNews) - Quidel Corporation (QDEL) and Ortho Clinical Diagnostics Holdings plc (OCDX) have entered an agreement, under which Quidel will acquire Ortho for 24.68 per share of common stock using. Fawn Creek Township is in Montgomery County. Ortho Clinical Diagnostics is now QuidelOrtho, transforming the power of diagnostics into a healthier future for all Learn More EDUCATION New Lab2Life quarterly newsletter sign up now and stay informed DIAGNOSTICS Introducing new ISXM capabilities. Further, the combined company will be poised to meet patient testing needs at all points of the care continuum – reference labs, hospitals, physicians’ offices, urgent care centers and at-home / retail locations. Fawn Creek Township is located in Kansas with a population of 1,618. The combined organization will unite world-class technologies and platforms to benefit customers with expanded access to clinical chemistry, immunoassay, molecular diagnostics, immunohematology, donor screening, and point-of-care diagnostics offerings. QDEL - QuidelOrtho Corporation NasdaqGS - NasdaqGS Real Time Price. The combined company will also acquire Ortho’s existing net debt of $2.0 billion. accredited activities and help spread awareness and knowledge to the healthcare community regarding tick-borne diseases. Under the terms of the agreement, which was unanimously approved by the Board of Directors of each company, Quidel will acquire Ortho for $24.68 per share of common stock, for a total consideration of approximately $6.0 billion, including $1.75 billion of cash, funded through cash on the balance sheet and incremental borrowings. – The acquisition will create a global leader in diagnostics, bringing together two highly complementary portfolios with world-class technologies and platforms spanning high-throughput systems to near-patient and at-home testing. Quidel-Ortho: A Merger of Contrasts In 2021’s most notable IVD merger and acquisition, San-Diego, CA-based Quidel announced an acquisition of Raritan, N.J. SAN DIEGO, CA and RARITAN, NJ- (BUSINESS WIRE)- DecemQuidel Corporation (NASDAQ: QDEL) ('Quidel') and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) ('Ortho') today announced that they have entered into a definitive agreement in which Quidel will acquire Ortho, one of the world's largest in vitro diagnostics companies, fo. – Quidel Corporation (NASDAQ: QDEL) (“Quidel”) and Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) (“Ortho”) jointly announced that they have entered into a definitive agreement in which Quidel will acquire Ortho.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |